BioAtla settles shareholder derivative suit, pays $350K in fees after bylaw reforms

BioAtla, Inc.

Company paid $350,000 in attorneys' fees to settle claims over bylaw amendments imposing disclosure requirements on dissident director nominations.
BioAtla amended bylaws on April 22, 2024, to address challenged provisions; company denies all wrongdoing.
Delaware Court of Chancery closed the action on May 15, 2024, subject to filing notice to putative class.
Plaintiff alleged directors breached fiduciary duties by adopting bylaw amendments on January 5, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.